Zullo Investment Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-65
Closed -$1.76K 173
2022
Q4
$1.76K Hold
65
﹤0.01% 703
2022
Q3
$1K Hold
65
﹤0.01% 723
2022
Q2
$2K Hold
65
﹤0.01% 709
2022
Q1
$2K Hold
65
﹤0.01% 739
2021
Q4
$2K Buy
+65
New +$2.1K ﹤0.01% 745

Other funds holding AVNS

Zullo Investment Group's AVNS Position: Q1 2023 in Review

Zullo Investment Group sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 65 shares — an estimated $1.76K sold.

Zullo Investment Group first reported a position in AVNS in Q4 2021 and held it in 5 quarters. The position peaked at $2K in Q2 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

  • Zullo Investment Group reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 65 Avanos Medical shares in Q1 2023, an estimated $1.76K.
  • Zullo Investment Group first reported a position in Avanos Medical in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Avanos Medical position peaked at $2K in Q2 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.